54 days agoHHS OMH Unveils $3M Funding for Lupus Clinical Trials with Strong Minority Focus
The HHS Office of Minority Health has launched a $3 million funding initiative for FY 2026 to enhance inclusion in lupus clinical trials among underrepresented populations. With awards of up to $500,000, organizations are invited to submit applications by July 10, 2026, emphasizing health equity and minority health outreach.
68 days agoDARPA's RAPIID Program Aims for Shelf-Stable Blood Substitute by FY2029
DARPA's RAPIID program intends to create synthetic blood substitutes for battlefield use, targeting FDA approval by FY2029. The program seeks proposals addressing blood component development and delivery technologies, presenting a robust opportunity landscape for companies in medical innovation and regulatory compliance.
70 days agoVA Initiates MDMA-Assisted Therapy Trial for PTSD and Alcohol Use Disorder
The VA has launched a clinical trial for MDMA-assisted therapy, targeting PTSD and alcohol use disorder among Veterans. This initiative, in coordination with the FDA, presents procurement opportunities related to clinical research and mental health services.